Login / Signup

Effect of febuxostat on adverse events and mortality in gout in Taiwan: An interrupted time series analysis.

Ping-Han TsaiChang Fu KuoJia-Rou LiuPei-Ru LiLai-Chu See
Published in: International journal of rheumatic diseases (2023)
Febuxostat may reduce SJS and TEN in all gout patients but increase AMI, PCI, and all-cause mortality in gout patients with comorbidities.
Keyphrases